ATS 2024 Final Program

Click on the session title to view the speakers

227

TUESDAY • MAY 21

11:03 Depletion of Natural Killer Cells Suppresses Aspects of Cellular and Antibody-mediated

11:03 The Economic and Health Burden of COPD in North America Through 2050: A Scenario Analysis Based on Two Large Data Sources

Rejection Early Post-transplant in a Murine Model of Restrictive Allograft Syndrome

BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM C16 SEPSIS IN 2024: FROM BENCH TO BEDSIDE AND AROUND THE WORLD 9:15 a.m. - 11:15 a.m. San Diego Convention Center Ballroom 20A (Upper Level) Oral Presentations: 9:15 Identifying Pre-sepsis Opportunities for Risk Stratification in Diverse Healthcare Venues 9:27 Large Language Models Identify Presenting Symptoms Associated With Infectious Diagnoses, Multi-Drug Resistant Organisms, and Mortality in Clinical Notes of Patients With Suspected Infection 9:39 Organ Dysfunction Scoring Systems Scale With Dysregulated Host Responses Among Adults With Suspected Sepsis in Uganda: A Prospective Cohort Study 9:51 Latent Class Analyses of the CLOVERS Trial Reveal Novel Phenotypes of Sepsis Patients With Shock Presenting to the Emergency Department 10:03 Variation in Initial Fluid Resuscitation Volume and Type in Patients With Sepsis Across Michigan Hospitals 10:15 Machine Learning of Heterogeneous Response to Resuscitation Strategy in Patients With Sepsis-induced Hypotension 10:27 An International Multicenter Prospective Observational Clinical Study to Identify Gene-expression Sepsis Immune Subgroups and Their Associations With Clinical Outcomes 10:39 Longitudinal Lower Airway and Systemic Host Response in Patients With Severe COVID-19 Pneumonia 10:51 Validation of Septic Shock Metabolic Phenotypes, Trajectory Over Time and Association With Outcome

BEHAVIORAL • CLINICAL MINI SYMPOSIUM

C15 COPD EPIDEMIOLOGY, TREATMENT, AND DISPARITIES 9:15 a.m. - 11:15 a.m. San Diego Convention Center Room 8 (Upper Level) Oral Presentations: 9:15 Efficacy of Mepolizumab in Patients With Chronic Obstructive Pulmonary Disease With or Without Chronic Bronchitis: Post Hoc Analysis of the METREX and METREO Phase 3 Trials 9:27 Short-term Outcomes of Endobronchial Valve Placement for Chronic Obstructive Pulmonary Disease in Patients With Underlying Cardiac Arrhythmias: A Propensity Matched National Study 9:39 Impact of Long-term Domiciliary Non Invasive Ventilation (NIV) on Severe Exacerbations and Survival in Patients With Chronic Obstructive Pulmonary Disease (COPD): A Nationwide Cohort Study Using Multistate Models 9:51 Childhood Cigarette Smoking and Risk of COPD in Older U.S. Adults 10:03 Social Isolation, Loneliness, and All-cause Mortality Risk in Older Adults With Chronic Obstructive Pulmonary Disease: A National Longitudinal Study 10:15 United States County-level Social Vulnerability and Chronic Obstructive Pulmonary Disease Mortality 10:27 Geographic Disparities in Tobacco Dependence Treatment Among Patients With COPD in a National Cohort 10:39 Food Insecurity Is Associated With Higher COPD Mortality 10:51 Cost-Related Nonadherence in the Medication Adherence Research in COPD (MARC) Study

ATS 2024 Conference Program • San Diego, CA